Reported Oct 18, 2017 · Terminated
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI)…
Boehringer Ingelheim Pharmaceuticals, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Boehringer Ingelheim Pharmaceuticals, Inc. · 39 Briar Ridge Rd. · Danbury, CT · 06810
Is this the product you have?
- Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist
- byBoehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic
- fromBI Int'l GmbH, Made in Italy, NDC 0597-0030-01
- Lot codes and dates
- Lot 754037
- Amount recalled
- 128 bottles
Where it was sold
Why it was recalled
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Boehringer Ingelheim Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.